In humans, low expression of the VEGFA haplotype increases the risk of a cardiac phenotype of DGS/VCFS, indicating that expression levels of VEGFA affect the severity of DGS/VCFS phenotypes [87]. Here, VEGFA is linked to 22q11.2 deletion syndrome.